The vaccine, which was developed in partnership with Oxford University, is awaiting approval from the Medicines and Healthcare products Regulatory…
Canberra is still waiting for more than 3 million doses of AstraZeneca’s jab that were supposed to be delivered from…
The US Department of Health & Human Services has given Johnson & Johnson full responsibility of the Emergent BioSolutions facility…
The British-Swedish pharmaceutical has rebranded its jab, which previously went by the simple ‘AstraZeneca Covid-19 Vaccine’, to ‘Vaxzevria’. In a…
The move comes after a recommendation from Canada’s National Advisory Committee on Immunization on Monday, which called for a pause…
The pharma firm publicized the results of its 32,000-person US trial in the early hours of Thursday morning, reporting that…
On Monday, the pharmaceutical giant released promising interim results from its US study, which showed its drug to have 79%…
On Monday, the embattled pharmaceutical giant AstraZeneca published positive results from its US trial, which showed the jab to have…
“We have the option of prohibiting a planned export. That is the message to AstraZeneca,” the EU Commission president told…
A research team from Germany's Greifswald University Hospital have discovered a mechanism that could lead to the development of sinus…